{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:29:36Z","timestamp":1788352176675,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Renal medullary carcinoma (RMC) is a rare subtype of renal cell carcinoma, typically described in young patients with sickle cell trait, which follows an aggressive course. We aimed to perform a systematic review of all published cases of RMC from 1995 to 2024, to summarise the clinico-pathological and radiological features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review of all published cases of RMC from 1995 to 2024 was performed. Patient demographics, clinical presentation, radiological features, metastatic profile, management, and overall survival were recorded. Sub-analysis was performed, grouped by sickle cell status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      219 cases from 103 articles were included, in addition to 5 previously unreported cases from our institution. 88% of patients had sickle cell haemoglobinopathy (SCH) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009168\/192), with presentation at a younger age in patients with SCH (27.3\u2009\u00b1\u200913.7 versus 34.1\u2009\u00b1\u200919.1\u00a0years,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). RMC was more frequently observed in the right kidney (64.6%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009122\/189) than the left kidney (35.4%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200967\/189) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009= &lt;\u20090.001). Radiologically, the most common features were a central\/endophytic location, hypo-enhancement relative to the adjacent cortex, and infiltrative margins. 20.7% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200942\/203) were stage III at presentation and 70.9% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009144\/203) of patients were Stage IV. Overall survival at 3\u00a0years was 74% for Stage I\u2013II disease, 23% for Stage III disease, and 9% for Stage IV disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Regardless of sickle cell status, RMC was shown to present at a relatively young age. It was classically seen as an infiltrative, poorly defined, endophytic tumour, centred on the renal medulla. RMC was found to be more commonly advanced at presentation and the overall survival in patients with nodal or distant metastases was poor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11255-026-05113-4","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:24:13Z","timestamp":1775737453000},"page":"3407-3418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Renal medullary carcinoma: a systematic review of clinical and radiological findings"],"prefix":"10.1007","volume":"58","author":[{"given":"William","family":"Weston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherry","family":"Sit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derfel Ap","family":"Dafydd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kelly-Morland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aslam","family":"Sohaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Adamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thubeena","family":"Manickavasagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Withey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"1","key":"5113_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-199501000-00001","volume":"19","author":"CJ Davis Jr.","year":"1995","unstructured":"Davis CJ Jr., Mostofi FK, Sesterhenn IA (1995) Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol 19(1):1\u201311","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"5113_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1200\/JOP.2017.020909","volume":"13","author":"KE Beckermann","year":"2017","unstructured":"Beckermann KE, Sharma D, Chaturvedi S, Msaouel P, Abboud MR, Allory Y et al (2017) Renal medullary carcinoma: establishing standards in practice. J Oncol Pract 13(7):414\u2013421","journal-title":"J Oncol Pract"},{"issue":"4","key":"5113_CR3","volume":"16","author":"PR Goswami","year":"2024","unstructured":"Goswami PR, Singh G, Patel T, Dave R (2024) The WHO 2022 classification of renal neoplasms (5th edition): salient updates. Cureus 16(4):e58470","journal-title":"Cureus"},{"issue":"6","key":"5113_CR4","doi-asserted-by":"publisher","first-page":"e987","DOI":"10.1016\/j.clgc.2017.04.012","volume":"15","author":"MI Carlo","year":"2017","unstructured":"Carlo MI, Chaim J, Patil S, Kemel Y, Schram AM, Woo K et al (2017) Genomic characterization of renal medullary carcinoma and treatment outcomes. Clin Genitourin Cancer 15(6):e987\u2013e994","journal-title":"Clin Genitourin Cancer"},{"key":"5113_CR5","volume-title":"AJCC cancer staging manual","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM (eds) (2017) AJCC cancer staging manual, 8th edn. Springer, Cham (CH)","edition":"8"},{"issue":"2","key":"5113_CR6","first-page":"114","volume":"66","author":"NS Johal","year":"2005","unstructured":"Johal NS, Desai D, Cuckow PM (2005) Renal medullary carcinoma: beware of diagnosing a urinary tract infection in a young sickle cell patient. Hosp Med 66(2):114\u2013115","journal-title":"Hosp Med"},{"issue":"6","key":"5113_CR7","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1016\/S0022-5347(01)64734-7","volume":"157","author":"JC Herring","year":"1997","unstructured":"Herring JC, Schmetz MA, Digan AB, Young ST, Kalloo NB (1997) Renal medullary carcinoma: a recently described highly aggressive renal tumor in young black patients. J Urol 157(6):2246\u20132247","journal-title":"J Urol"},{"issue":"4","key":"5113_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/(SICI)1097-0339(199804)18:4<276::AID-DC5>3.0.CO;2-A","volume":"18","author":"DM Larson","year":"1998","unstructured":"Larson DM, Gilstad CW, Manson GW, Henry MR (1998) Renal medullary carcinoma: report of a case with positive urinary cytology. Diagn Cytopathol 18(4):276\u2013279","journal-title":"Diagn Cytopathol"},{"issue":"7","key":"5113_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/DAD.0b013e3182106f2c","volume":"33","author":"VE Nava","year":"2011","unstructured":"Nava VE, Mullin BR, Schuldenfrei JA (2011) Renal medullary carcinoma metastatic to forehead. Am J Dermatopathol 33(7):757","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"5113_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1464-410X.2009.09139.x","volume":"106","author":"EM Schaeffer","year":"2010","unstructured":"Schaeffer EM, Guzzo TJ, Furge KA, Netto G, Westphal M, Dykema K et al (2010) Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy. BJU Int 106(1):62\u201365","journal-title":"BJU Int"},{"issue":"1","key":"5113_CR11","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/DAD.0b013e3181e4b4eb","volume":"33","author":"RP Johnson","year":"2011","unstructured":"Johnson RP, Krauland K, Owens NM, Peckham S (2011) Renal medullary carcinoma metastatic to the scalp. Am J Dermatopathol 33(1):e11\u2013e13","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"5113_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/cncr.20764","volume":"105","author":"L Assad","year":"2005","unstructured":"Assad L, Resetkova E, Oliveira VL, Sun W, Stewart JM, Katz RL et al (2005) Cytologic features of renal medullary carcinoma. Cancer 105(1):28\u201334","journal-title":"Cancer"},{"issue":"4","key":"5113_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/01.IOP.0000129530.75840.49","volume":"20","author":"LA Zdinak","year":"2004","unstructured":"Zdinak LA, Nik NA, Hidayat AA, Hargett NA (2004) Renal medullary carcinoma metastatic to the orbit: a clinicopathologic report. Ophthalmic Plast Reconstr Surg 20(4):322\u2013325","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"6","key":"5113_CR14","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1097\/IOP.0000000000001478","volume":"35","author":"R Chumdermpadetsuk","year":"2019","unstructured":"Chumdermpadetsuk R, Tooley AA, Godfrey KJ, Krawitz B, Feldstein N, Kazim M (2019) Renal medullary carcinoma with metastasis to the temporal fossa and orbit. Ophthalmic Plast Reconstr Surg 35(6):e149\u2013e151","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"5113_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/0974-7796.204184","volume":"9","author":"C Ibilibor","year":"2017","unstructured":"Ibilibor C, Medway A, Nelius T (2017) Renal medullary carcinoma with an ophthalmic metastasis. Urol Ann 9(2):184\u2013187","journal-title":"Urol Ann"},{"key":"5113_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.humpath.2017.07.006","volume":"67","author":"D Sirohi","year":"2017","unstructured":"Sirohi D, Smith SC, Ohe C, Colombo P, Divatia M, Dragoescu E et al (2017) Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma. Hum Pathol 67:134\u2013145","journal-title":"Hum Pathol"},{"issue":"6","key":"5113_CR17","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/(SICI)1096-911X(199912)33:6<551::AID-MPO5>3.0.CO;2-5","volume":"33","author":"J Stahlschmidt","year":"1999","unstructured":"Stahlschmidt J, Cullinane C, Roberts P, Picton SV (1999) Renal medullary carcinoma: prolonged remission with chemotherapy, immunohistochemical characterisation and evidence of bcr\/abl rearrangement. Med Pediatr Oncol 33(6):551\u2013557","journal-title":"Med Pediatr Oncol"},{"issue":"9","key":"5113_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27267","volume":"65","author":"MA Carden","year":"2018","unstructured":"Carden MA, Perdahl-Wallace E, Greenberg J, McCarty JM (2018) Autologous stem-cell transplant for metastatic renal medullary carcinoma. Pediatr Blood Canc 65(9):e27267","journal-title":"Pediatr Blood Canc"},{"issue":"3","key":"5113_CR19","first-page":"169","volume":"4","author":"M Anne","year":"2013","unstructured":"Anne M, Sammartino D, Chaudhary S, Bhuiya T, Mehrotra B (2013) Renal medullary carcinoma masquerading as bilateral breast carcinoma category: case report. World J Oncol 4(3):169\u2013172","journal-title":"World J Oncol"},{"issue":"6","key":"5113_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/01913120802591875","volume":"32","author":"EP Wartchow","year":"2008","unstructured":"Wartchow EP, Trost BA, Tucker JA, Albano EA, Mierau GW (2008) Renal medullary carcinoma: ultrastructural studies may benefit diagnosis. Ultrastruct Pathol 32(6):252\u2013256","journal-title":"Ultrastruct Pathol"},{"issue":"4","key":"5113_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/pbc.20292","volume":"44","author":"JJ Strouse","year":"2005","unstructured":"Strouse JJ, Spevak M, Mack AK, Arceci RJ, Small D, Loeb DM (2005) Significant responses to platinum-based chemotherapy in renal medullary carcinoma. Pediatr Blood Canc 44(4):407\u2013411","journal-title":"Pediatr Blood Canc"},{"issue":"9","key":"5113_CR22","volume":"12","author":"F Basher","year":"2020","unstructured":"Basher F, Dutcher G, England JS, Lopes G (2020) Unusual presentation of renal medullary carcinoma with undiagnosed sickle cell trait. Cureus 12(9):e10731","journal-title":"Cureus"},{"issue":"5","key":"5113_CR23","first-page":"2837","volume":"12","author":"G Molgat","year":"2005","unstructured":"Molgat G, Afrouzian M, Trpkov K (2005) Renal medullary carcinoma as an incidental finding in a horseshoe kidney: case report and literature review. Can J Urol 12(5):2837\u20132840","journal-title":"Can J Urol"},{"issue":"2","key":"5113_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5301\/uro.5000097","volume":"82","author":"GB Levi Sandri","year":"2015","unstructured":"Levi Sandri GB, Spoletini G, Lai Q, Mennini G, Rossi M (2015) Cystic presentation of a renal medullary carcinoma in a young woman. Urologia 82(2):124\u2013126","journal-title":"Urologia"},{"issue":"2","key":"5113_CR25","first-page":"270","volume":"14","author":"A Shetty","year":"2014","unstructured":"Shetty A, Matrana MR (2014) Renal medullary carcinoma: a case report and brief review of the literature. Ochsner J 14(2):270\u2013275","journal-title":"Ochsner J"},{"issue":"1","key":"5113_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11934-019-0865-9","volume":"20","author":"L Blas","year":"2019","unstructured":"Blas L, Roberti J, Petroni J, Reniero L, Cicora F (2019) Renal medullary carcinoma: a report of the current literature. Curr Urol Rep 20(1):4","journal-title":"Curr Urol Rep"},{"issue":"10","key":"5113_CR27","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1097\/PAS.0b013e31822b325b","volume":"35","author":"TJ Hollmann","year":"2011","unstructured":"Hollmann TJ, Hornick JL (2011) INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol 35(10):e47-63","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"5113_CR28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2559.2012.04228.x","volume":"61","author":"J Calderaro","year":"2012","unstructured":"Calderaro J, Moroch J, Pierron G, Pedeutour F, Grison C, Maill\u00e9 P et al (2012) SMARCB1\/INI1 inactivation in renal medullary carcinoma. Histopathology 61(3):428\u2013435","journal-title":"Histopathology"},{"key":"5113_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.humpath.2022.03.002","volume":"124","author":"D Kiyozawa","year":"2022","unstructured":"Kiyozawa D, Kohashi K, Takamatsu D, Iwasaki T, Shibata D, Tomonaga T et al (2022) Approach for reclassification of collecting duct carcinoma and comparative histopathological analysis with SMARCB1\/INI1-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma. Hum Pathol 124:36\u201344","journal-title":"Hum Pathol"},{"issue":"9","key":"5113_CR30","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1158\/1078-0432.CCR-17-3296","volume":"24","author":"P Msaouel","year":"2018","unstructured":"Msaouel P, Tannir NM, Walker CL (2018) A model linking sickle cell hemoglobinopathies and SMARCB1 loss in renal medullary carcinoma. Clin Canc Res 24(9):2044\u20132049","journal-title":"Clin Canc Res"},{"issue":"10","key":"5113_CR31","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/pbc.25592","volume":"62","author":"O Alvarez","year":"2015","unstructured":"Alvarez O, Rodriguez MM, Jordan L, Sarnaik S (2015) Renal medullary carcinoma and sickle cell trait: a systematic review. Pediatr Blood Canc 62(10):1694\u20131699","journal-title":"Pediatr Blood Canc"},{"issue":"6","key":"5113_CR32","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.eururo.2015.09.027","volume":"69","author":"J Calderaro","year":"2016","unstructured":"Calderaro J, Masliah-Planchon J, Richer W, Maillot L, Maille P, Mansuy L et al (2016) Balanced translocations disrupting smarcb1 are hallmark recurrent genetic alterations in renal medullary carcinomas. Eur Urol 69(6):1055\u20131061","journal-title":"Eur Urol"},{"key":"5113_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2369-6-10","volume":"6","author":"S Bemanian","year":"2005","unstructured":"Bemanian S, Motallebi M, Nosrati SM (2005) Cocaine-induced renal infarction: report of a case and review of the literature. BMC Nephrol 6:10","journal-title":"BMC Nephrol"},{"issue":"6","key":"5113_CR34","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1148\/rg.266065010","volume":"26","author":"SR Prasad","year":"2006","unstructured":"Prasad SR, Humphrey PA, Catena JR, Narra VR, Srigley JR, Cortez AD et al (2006) Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 26(6):1795\u20131806","journal-title":"Radiographics"},{"issue":"6","key":"5113_CR35","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.2214\/AJR.13.10813","volume":"201","author":"SP Raman","year":"2013","unstructured":"Raman SP, Johnson PT, Allaf ME, Netto G, Fishman EK (2013) Chromophobe renal cell carcinoma: multiphase MDCT enhancement patterns and morphologic features. Am J Roentgenol 201(6):1268\u20131276","journal-title":"Am J Roentgenol"},{"issue":"3","key":"5113_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ejrad.2005.09.009","volume":"57","author":"SK Yoon","year":"2006","unstructured":"Yoon SK, Nam KJ, Rha SH, Kim JK, Cho KS, Kim B et al (2006) Collecting duct carcinoma of the kidney: CT and pathologic correlation. Eur J Radiol 57(3):453\u2013460","journal-title":"Eur J Radiol"},{"issue":"3","key":"5113_CR37","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2214\/ajr.176.3.1760627","volume":"176","author":"PJ Pickhardt","year":"2001","unstructured":"Pickhardt PJ, Siegel CL, McLarney JK (2001) Collecting duct carcinoma of the kidney. Am J Roentgenol 176(3):627\u2013633","journal-title":"Am J Roentgenol"},{"issue":"1","key":"5113_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2214\/ajr.185.1.01850268","volume":"185","author":"NM Blitman","year":"2005","unstructured":"Blitman NM, Berkenblit RG, Rozenblit AM, Levin TL (2005) Renal medullary carcinoma: CT and MRI features. AJR Am J Roentgenol 185(1):268\u2013272","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"5113_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15586\/jkcvhl.2017.62","volume":"4","author":"F Greco","year":"2017","unstructured":"Greco F, Faiella E, Santucci D, Mallio CA, Nezzo M, Quattrocchi CC et al (2017) Imaging of renal medullary carcinoma. J Kidney Canc VHL 4(1):1\u20137","journal-title":"J Kidney Canc VHL"},{"issue":"1","key":"5113_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.eururo.2008.09.052","volume":"55","author":"JH Blom","year":"2009","unstructured":"Blom JH, van Poppel H, Mar\u00e9chal JM, Jacqmin D, Schr\u00f6der FH, de Prijck L et al (2009) Radical nephrectomy with and without lymph-node dissection: final results of European organization for research and treatment of cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 55(1):28\u201334","journal-title":"Eur Urol"},{"issue":"1","key":"5113_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0022-5347(05)65382-7","volume":"167","author":"LM Hock","year":"2002","unstructured":"Hock LM, Lynch J, Balaji KC (2002) Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 167(1):57\u201360","journal-title":"J Urol"},{"issue":"15_suppl","key":"5113_CR42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.e16075","volume":"35","author":"D Niewiadomski","year":"2017","unstructured":"Niewiadomski D, Acuna CL, Morgenfeld EL, Tognelli F, Smolje L, Montiel M et al (2017) Incidental vs. clinical diagnosis of renal cell carcinoma (RCC): population, treatment and outcome in a cohort of 828 patients followed at Instituto Oncol\u00f3gico Henry Moore (IOHM). J Clin Oncol 35(15_suppl):e16075-e","journal-title":"J Clin Oncol"},{"key":"5113_CR43","unstructured":"National Cancer Institute. SEER cancer stat facts: kidney and renal pelvis cancer. Bethesda (MD): National Cancer Institute: Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/kidrp.html."}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05113-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05113-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05113-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:40:50Z","timestamp":1787654450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05113-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5113"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05113-4","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}